Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines for COVID-19 and shingles, migraine treatments, and blockbuster cancer drugs, according to data ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration ...

Older adults discharged from hospitals on multiple medications are less likely to regain independence during rehabilitation, a new study suggests. The Japanese study, published in the journal BMC ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

Dec. 19 (UPI) --President Donald Trump on Friday announced that nine of the largest drugmakers in the United States and Europe have agreed to voluntarily sell their medications at lower prices in a ...

President Donald Trump has signed an executive order making some big changes to marijuana policy, the most substantial since 1970. On Dec. 18, Trump ordered the government to stop classifying ...

More than 11,000 bottles of a common blood pressure medication have been recalled nationwide. Bisoprolol fumarate and hydrochlorothiazide tablets made by Glenmark Pharmaceuticals may contain trace ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Elaine Chen covers biotech, ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...